CASI Pharmaceuticals
CASI
#8912
Rank
S$0.11 B
Marketcap
$7.16
Share price
-3.96%
Change (1 day)
18.84%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2024 (TTM): -S$36.27 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are S$23.1 Million. In 2023 the company made an earning of -S$35.41 Million, an increase over its 2022 earnings that were of -S$50.26 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$36.27 Million2.44%
2023 -S$35.41 Million-29.55%
2022 -S$50.26 Million4.43%
2021 -S$48.13 Million-24.56%
2020 -S$63.79 Million4.74%
2019 -S$60.91 Million65.13%
2018 -S$36.89 Million155.07%
2017 -S$14.47 Million13.93%
2016 -S$12.7 Million31.18%
2015 -S$9.68 Million-72.5%
2014 -S$35.18 Million356.62%
2013 -S$7.71 Million-60.55%
2012 -S$19.53 Million218.41%
2011 -S$6.14 Million0.74%
2010 -S$6.09 Million-32.54%
2009 -S$9.03 Million-66.98%
2008 -S$27.34 Million-14.22%
2007 -S$31.87 Million7.04%
2006 -S$29.77 Million27.95%
2005 -S$23.27 Million4.51%
2004 -S$22.27 Million-15.84%
2003 -S$26.45 Million-55.29%
2002 -S$59.17 Million-34.05%
2001 -S$89.71 Million31.73%
2000 -S$68.1 Million31.56%
1999 -S$51.77 Million145.56%
1998 -S$21.08 Million76.4%
1997 -S$11.95 Million36.92%
1996 -S$8.73 Million